{"id":"tramadol","brandName":"Ultram","genericName":"tramadol","companyId":"johnson-johnson","companyName":"Janssen","phase":"marketed","status":"active","modality":"","aliases":[],"developmentCodes":[],"firstApprovalDate":null,"firstApprovalCountry":null,"aiSummary":"","enrichmentLevel":3,"visitCount":1,"mechanism":{"target":"Solute carrier family 22 member 1, Delta-type opioid receptor, Kappa-type opioid receptor"},"administration":{"route":"Oral"},"safety":{"boxedWarnings":["WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE TABLETS Addiction, Abuse, and Misuse Because the use of tramadol hydrochloride extended-release tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1)] . Life-Threatening Respiratory Depression Serious, life-threatening, or fatal respiratory depression may occur with use of tramadol hydrochloride extended-release tablets , especially during initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration of tramadol hydrochloride extended-release tablets are essential [see Warnings and Precautions (5.2)]. Instruct patients to swallow tramadol hydrochloride extended-release tablets whole to avoid exposure to a potentially fatal dose of tramadol [see Warnings and Precautions (5.2)]. Accidental Ingestion Accidental ingestion of even one dose of tramadol hydrochloride extended-release tablets , especially by children, can result in a fatal overdose of tramadol [see Warnings and Precautions (5.2)] . Risks From Concomitant Use With Benzodiazepines Or Other CNS Depressants Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing of tramadol hydrochloride extended-release tablets and benzodiazepines or other CNS depressants for use in patients for whom alternative treatment options are inadequate [see Warnings and Precautions (5.3), Drug Interactions (7)] . Neonatal Opioid Withdrawal Syndrome (NOWS) Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be life-threatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery [see Warnings and Precautions (5.4)] . Opioid Analgesic Risk Evaluation and Mitigation Strategy (REMS) Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription [see Warnings and Precautions (5.5)] . Ultra-Rapid Metabolism Of Tramadol And Other Risk Factors For Life-Threatening Respiratory Depression In Children Life-threatening respiratory depression and death have occurred in children who received tramadol. Some of the reported cases followed tonsillectomy and/or adenoidectomy, and in at least one case, the child had evidence of being an ultra-rapid metabolizer of tramadol due to a CYP2D6 polymorphism [ see Warnings and Precautions (5.6) ]. Tramadol hydrochloride extended-release tablets are contraindicated in children younger than 12 years of age and in children younger than 18 years of age following tonsillectomy and/or adenoidectomy [ see Contraindications (4) ] . Avoid the use of tramadol hydrochloride extended-release tablets in adolescents 12 to 18 years of age who have other risk factors that may increase their sensitivity to the respiratory depressant effects of tramadol. [see Warnings and Precautions (5.6)] Interactions with Drugs Affecting Cytochrome P450 Isoenzymes The effects of concomitant use or discontinuation of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol are complex. Use of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol hydrochloride extended-release tablets requires careful consideration of the effects on the parent drug, tramadol, and the active metabolite, M1 [see Warnings and Precautions (5.7), Drug Interactions (7)] . WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE TABLETS See full prescribing information for complete boxed warning . Tramadol hydrochloride extended-release tablets expose users to risks of addiction, abuse, and misuse, which can lead to overdose and death. Assess patient’s risk before prescribing and reassess regularly for these behaviors and conditions. (5.1) Serious, life-threatening, or fatal respiratory depression may occur, especially upon initiation or following a dosage increase. To reduce the risk of respiratory depression, proper dosing and titration are essential. Instruct patients to swallow tramadol hydrochloride extended-release tablets whole to avoid exposure to a potentially fatal dose of tramadol. (5.2) Accidental ingestion of tramadol hydrochloride extended-release tablets, especially by children, can result in a fatal overdose of tramadol. (5.2) Concomitant use of opioids with benzodiazepines or other central nervous system (CNS) depressants, including alcohol, may result in profound sedation, respiratory depression, coma, and death. Reserve concomitant prescribing for use in patients for whom alternative treatment options are inadequate; limit dosages and durations to the minimum required; and follow patients for signs and symptoms of respiratory depression and sedation. (5.3, 7) Advise pregnant women using opioids for an extended period of time of the risk of Neonatal Opioid Withdrawal Syndrome, which may be lifethreatening if not recognized and treated. Ensure that management by neonatology experts will be available at delivery. (5.4) • Healthcare providers are strongly encouraged to complete a REMS-compliant education program and to counsel patients and caregivers on serious risks, safe use, and the importance of reading the Medication Guide with each prescription (5.5). Tramadol hydrochloride extended-release tablets are contraindicated in children younger than 12 years of age and in children younger than 18 years of age following tonsillectomy and/or adenoidectomy. (4) Avoid the use of Tramadol hydrochloride extended-release tablets in adolescents 12 to 18 years of age who have other risk factors that may increase their sensitivity to the respiratory depressant effects of tramadol. (5.6) The effects of concomitant use or discontinuation of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol are complex. Use of cytochrome P450 3A4 inducers, 3A4 inhibitors, or 2D6 inhibitors with tramadol hydrochloride extended-release tablets requires careful consideration of the effects on the parent drug, tramadol, and the active metabolite, M1 (5.7, 7)"],"safetySignals":[{"date":"","signal":"DEPENDENCE","source":"FDA FAERS","actionTaken":"7820 reports"},{"date":"","signal":"OVERDOSE","source":"FDA FAERS","actionTaken":"3862 reports"},{"date":"","signal":"VOMITING","source":"FDA FAERS","actionTaken":"3199 reports"},{"date":"","signal":"PAIN","source":"FDA FAERS","actionTaken":"2925 reports"},{"date":"","signal":"NAUSEA","source":"FDA FAERS","actionTaken":"2785 reports"},{"date":"","signal":"DRUG INEFFECTIVE","source":"FDA FAERS","actionTaken":"2546 reports"},{"date":"","signal":"HEADACHE","source":"FDA FAERS","actionTaken":"2305 reports"},{"date":"","signal":"FATIGUE","source":"FDA FAERS","actionTaken":"2282 reports"},{"date":"","signal":"OFF LABEL USE","source":"FDA FAERS","actionTaken":"2248 reports"},{"date":"","signal":"DYSPNOEA","source":"FDA FAERS","actionTaken":"2241 reports"}],"drugInteractions":[],"commonSideEffects":[{"effect":"Dizziness/Vertigo","drugRate":"","severity":"common","organSystem":""},{"effect":"Nausea","drugRate":"","severity":"common","organSystem":""},{"effect":"Constipation","drugRate":"","severity":"common","organSystem":""},{"effect":"Headache","drugRate":"","severity":"common","organSystem":""},{"effect":"Somnolence","drugRate":"","severity":"common","organSystem":""},{"effect":"Vomiting","drugRate":"","severity":"common","organSystem":""},{"effect":"Pruritus","drugRate":"","severity":"common","organSystem":""}],"contraindications":["Acute nephropathy","Alcohol intoxication","Alcohol withdrawal syndrome","Alcoholism","Benign intracranial hypertension","Benzodiazepine Toxicity","Central nervous system depression","Cirrhosis of liver","Decreased respiratory function","Depressive disorder","Diabetes mellitus","Disease of liver","Drug withdrawal","Epilepsy","Hepatic failure","Hyperlipidemia","Hypertensive disorder","Infectious disease of central nervous system","Injury of head","Lowered convulsive threshold","Poisoning by acetaminophen","Poisoning by opiate analgesic drug","Pregnancy, function","Seizure disorder","Serotonin syndrome","Substance abuse","Suicidal","Suicidal thoughts"],"specialPopulations":{},"discontinuationRates":[],"seriousAdverseEvents":[{"effect":"Serotonin syndrome","drugRate":"<1%","severity":"serious"},{"effect":"Seizure","drugRate":"<1%","severity":"serious"},{"effect":"Anaphylaxis","drugRate":"<1%","severity":"serious"},{"effect":"Stevens-Johnson syndrome/Toxic epidermal necrolysis","drugRate":"<1%","severity":"serious"},{"effect":"Suicidal tendency","drugRate":"<1%","severity":"serious"},{"effect":"Death","drugRate":"<1%","severity":"serious"},{"effect":"Syncope","drugRate":"<1%","severity":"serious"},{"effect":"Hallucinations","drugRate":"<1%","severity":"serious"},{"effect":"Dyspnea","drugRate":"<1%","severity":"serious"},{"effect":"Orthostatic hypotension","drugRate":"<1%","severity":"serious"}]},"trials":["NCT07113782","NCT02412930","NCT02801968","NCT07289321","NCT02497326","NCT07149584","NCT03365817","NCT00981929","NCT06415331","NCT07096765","NCT01920386","NCT04939987","NCT07057934","NCT06425718","NCT04574791","NCT05401916","NCT01778075","NCT05752734","NCT02419651","NCT03477851","NCT04906239","NCT07500454","NCT01782846","NCT05822492","NCT06601530","NCT00634543","NCT04330547","NCT06231043","NCT00735748","NCT01930318","NCT02076893","NCT07051499","NCT03134729","NCT00564603","NCT07386288","NCT06834243","NCT01563380","NCT05311722","NCT01345162","NCT05886231","NCT02291705","NCT03586934","NCT00426647","NCT02544282","NCT00737048","NCT03640247","NCT04147013","NCT00347685","NCT00772967","NCT06343259"],"indications":{"approved":[{"name":"Chronic pain","diseaseId":"chronic-pain","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Osteoarthritis","diseaseId":"osteoarthritis","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"},{"name":"Pain","diseaseId":"pain","approvalDate":"","lineOfTherapy":"","approvalCountry":"United States"}],"offLabel":[],"pipeline":[]},"commercial":null,"patents":[],"timeline":[],"rwe":[],"competitors":[],"ownershipHistory":[],"trialDetails":[{"nctId":"NCT07113782","phase":"Phase 4","title":"Comparison of Magnesium Sulphate vs Tramadol as Adjuvants in Intrathecal Bupivacaine for Postoperative Pain in TURP Patients","status":"COMPLETED","sponsor":"Armed Forces Institute of Urology, Rawalpindi","isPivotal":false,"enrollment":60,"indication":"Benign Prostatic Hyperplasia Postoperative Pain","completionDate":"2025-04-30"},{"nctId":"NCT02412930","phase":"Phase 4","title":"Comparative Study of Ultrasound-guided Paravertebral Block Versus Intravenous Tramadol for Postoperative Pain Control in Percutaneous Nephrolithotomy","status":"COMPLETED","sponsor":"Cukurova University","isPivotal":false,"enrollment":53,"indication":"Postoperative Pain","completionDate":"2016-04"},{"nctId":"NCT02801968","phase":"NA","title":"","status":"UNKNOWN","sponsor":"S. Anna Hospital","isPivotal":false,"enrollment":62,"indication":"Cesarean Delivery","completionDate":"2016-09"},{"nctId":"NCT07289321","phase":"NA","title":"Effect of Tramadol or Magnesium in Local Anesthetic Solution on Ultrasound-guided Bilateral TAP Block During Robotic Radical Prostatectomy on Acute Perioperative Pain and Chronic Postoperative Pain.","status":"ENROLLING_BY_INVITATION","sponsor":"Aretaieion University Hospital","isPivotal":false,"enrollment":90,"indication":"Perioperative Pain in Robotic Prostatectomy","completionDate":"2028-12-10"},{"nctId":"NCT02497326","phase":"NA","title":"Comparative Study of Conventional and Topical Heparin Treatments in Second Degree Burn Patients for Burn Analgesia and Duration of Wound Healing","status":"UNKNOWN","sponsor":"King Edward Medical University","isPivotal":false,"enrollment":36,"indication":"Second Degree Burns","completionDate":"2015-12"},{"nctId":"NCT07149584","phase":"NA","title":"Erector Spinae Plane Block Versus Thoracic Paravertebral Block in Laparoscopic Cholecystectomy: A Randomized Controlled Trial on Opioid Consumption","status":"COMPLETED","sponsor":"Istanbul University","isPivotal":false,"enrollment":120,"indication":"Pain, Acute Postoperative","completionDate":"2026-02-23"},{"nctId":"NCT03365817","phase":"Phase 3","title":"Cognitive Function and Addiction in Patients With Chronic Pain Under Opioid Tapering in a Multidisciplinary Pain Treatment","status":"COMPLETED","sponsor":"Rigshospitalet, Denmark","isPivotal":true,"enrollment":75,"indication":"Chronic Pain, Opioid Use","completionDate":"2014-12-01"},{"nctId":"NCT00981929","phase":"NA","title":"Development of Cocktail for Measuring the Activity of Important Cytochrome P450 Enzymes","status":"TERMINATED","sponsor":"University of Southern Denmark","isPivotal":false,"enrollment":412,"indication":"Cytochrome P450 Phenotype and Genotype Metrics","completionDate":"2011-01"},{"nctId":"NCT06415331","phase":"NA","title":"Comparison of The Effectiveness Between Conventional Therapy and Conventional Therapy Plus Pulsed-Radiofrequency in Herniated Nucleus Pulposus Patients at Dr. Saiful Anwar Hospital, Malang","status":"COMPLETED","sponsor":"Dr. Syaiful Anwar Hospital, Malang","isPivotal":false,"enrollment":60,"indication":"Herniated Nucleus Pulposus, Pain","completionDate":"2023-09-16"},{"nctId":"NCT07096765","phase":"NA","title":"Effect of Injection Duration of Fascial Plane Blocks on Block Success and Postoperative Analgesia in Patients Undergoing Laparoscopic Cholecystectomy","status":"NOT_YET_RECRUITING","sponsor":"Bursa Yuksek Ihtisas Training and Research Hospital","isPivotal":false,"enrollment":100,"indication":"Nerve Block","completionDate":"2026-02-01"},{"nctId":"NCT01920386","phase":"Phase 3","title":"A Randomized, Double-blind, Active-controlled, Parallel, Multicenter Phase 3 Study of Tramadol Hydrochloride/Acetaminophen SR Tab. & Tramadol Hydrochloride/Acetaminophen Tab. in Acute Toothache Patien","status":"COMPLETED","sponsor":"Daewon Pharmaceutical Co., Ltd.","isPivotal":true,"enrollment":240,"indication":"Acute Toothache Patients Above Moderate Pain After Teeth Extraction Surgery","completionDate":""},{"nctId":"NCT04939987","phase":"Phase 2","title":"Opioid-Free Pain Control Regiment Following Robotic Radical Prostatectomy: A Randomized Controlled Trial","status":"WITHDRAWN","sponsor":"Wake Forest University Health Sciences","isPivotal":true,"enrollment":0,"indication":"Radical Prostatectomies","completionDate":"2022-10"},{"nctId":"NCT07057934","phase":"NA","title":"THE EFFECTS OF EXTERNAL OBLIQUE INTERCOSTAL PLAN BLOCK AND ERECTOR SPINA PLAN BLOCK ON POSTOPERATIVE ANALGESIA IN PATIENTS UNDERGOING LAPAROSCOPIC CHOLECYSTECTOMY OPERATION","status":"COMPLETED","sponsor":"Dr. Lutfi Kirdar Kartal Training and Research Hospital","isPivotal":false,"enrollment":90,"indication":"Postoperative Pain, Cholelithiasis","completionDate":"2024-06-30"},{"nctId":"NCT06425718","phase":"NA","title":"Comparison of Transversalis Fascia Plane Block and Surgical Site Local Anesthetic Infiltration in Elective Cesarean Section Surgeries","status":"COMPLETED","sponsor":"Marmara University","isPivotal":false,"enrollment":42,"indication":"Opioid Use, Postoperative Pain","completionDate":"2024-06-26"},{"nctId":"NCT04574791","phase":"NA","title":"Addition of Muscle Relaxants in a Multimodal Analgesic Regimen for Analgesia After Primary Total Knee Arthroplasty","status":"UNKNOWN","sponsor":"Rothman Institute Orthopaedics","isPivotal":false,"enrollment":240,"indication":"Pain, Postoperative","completionDate":"2021-09-30"},{"nctId":"NCT05401916","phase":"NA","title":"Efficacy of Intravenous Ibuprofen and Paracetamol on Postoperative Pain and Tramadol Consumption in Shoulder Surgery: Prospective, Randomized, Double-Blind Clinical Trial","status":"COMPLETED","sponsor":"Bezmialem Vakif University","isPivotal":false,"enrollment":2,"indication":"Postoperative Pain Management","completionDate":"2023-04-09"},{"nctId":"NCT01778075","phase":"Phase 1","title":"A Single Dose, Open-Label, Randomized, Two-Way Crossover Pivotal Study to Assess the Bioequivalence of a New ULTRACET ER Tablet With Respect to a Marketed ULTRACET ER Tablet Under Fasted Condition","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","isPivotal":false,"enrollment":56,"indication":"Healthy","completionDate":"2013-02"},{"nctId":"NCT05752734","phase":"N/A","title":"Preoperative Dexamethasone Enhances Quality of Recovery After Laparoscopic Bariatric Surgery: A Prospective Observational Study","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","isPivotal":false,"enrollment":60,"indication":"Anesthesia, Analgesia","completionDate":"2023-06-10"},{"nctId":"NCT02419651","phase":"Phase 3","title":"Tramadol Versus Diclofenac for Reducing Pain Associated With Outpatient Hysteroscopy: A Randomized Double Blind Placebo-Controlled Trial","status":"UNKNOWN","sponsor":"Cairo University","isPivotal":true,"enrollment":210,"indication":"Pain, Post Procedural, Pain, Procedural","completionDate":"2017-12"},{"nctId":"NCT03477851","phase":"Phase 4","title":"Evaluation of the Influence of Tramadol Injection Simultaneous With Sciatic Nerve Block on the Duration of Efficient Sensory Blockade in Patients Operated on for Calcaneus Fracture","status":"COMPLETED","sponsor":"Medical University of Warsaw","isPivotal":false,"enrollment":40,"indication":"Foot Fracture, Pain, Acute","completionDate":"2020-12-30"},{"nctId":"NCT04906239","phase":"NA","title":"The Effect of Bilateral Erector Spina Block on Postoperative Pain in Adult Cardiac Surgery: A Randomized, Clinical Study.","status":"COMPLETED","sponsor":"Kahramanmaras Sutcu Imam University","isPivotal":false,"enrollment":40,"indication":"Postoperative Pain, Opioid Use","completionDate":"2022-03-15"},{"nctId":"NCT07500454","phase":"NA","title":"Analgesic Equivalence of NSAIDs and a Weak Opioid in Acute Postoperative Pain Following Minimally Invasive Surgery Under Balanced General Anaesthesia: A Pilot Randomised Controlled Trial","status":"COMPLETED","sponsor":"ISSSTE Hospital Regional \"Gral. Ignacio Zaragoza\"","isPivotal":false,"enrollment":30,"indication":"Postoperative Pain, Acute Pain","completionDate":"2024-03-23"},{"nctId":"NCT01782846","phase":"Phase 4","title":"Double Blind-randomized Study Comparing the Efficacy of Two Analgesia (Ixprim® and Dafalgan-Codeine®) , in the Emergency Unit.","status":"COMPLETED","sponsor":"Hopital Foch","isPivotal":false,"enrollment":803,"indication":"Pain","completionDate":"2013-04"},{"nctId":"NCT05822492","phase":"N/A","title":"Comparison of the Effects of Anterior Quadratus Lumborum Block and Erector Spina Plane Block on Postoperative Acute Pain in Percutaneous Nephrolithotomy Surgery","status":"COMPLETED","sponsor":"Ondokuz Mayıs University","isPivotal":false,"enrollment":90,"indication":"Anesthesia, Analgesia","completionDate":"2023-09-30"},{"nctId":"NCT06601530","phase":"Phase 4","title":"Investigation of the Efficacy of Transversus Thoracic Muscle Plane Block in Patients Undergoing Coronary Artery Bypass Graft Surgery","status":"COMPLETED","sponsor":"Istanbul University - Cerrahpasa","isPivotal":false,"enrollment":46,"indication":"Coronary Artery Bypass, Anesthesia, Conduction","completionDate":"2022-10-01"},{"nctId":"NCT00634543","phase":"Phase 4","title":"Comparison of the Effectiveness and Safety Between Tramadol 37.5 Mg/Acetaminophen 325mg And Gabapentin for The Treatment of Painful Diabetic Neuropathy: Multicenter, Randomized, Open Comparative Study","status":"COMPLETED","sponsor":"Janssen Korea, Ltd., Korea","isPivotal":false,"enrollment":162,"indication":"Diabetic Neuropathy","completionDate":"2008-10"},{"nctId":"NCT04330547","phase":"Phase 1","title":"Use of Analgesic Treatment to Reduce Signs of Pain in Patients With Disorders of Consciousness: a Double-blind Placebo-controlled Clinical Study.","status":"COMPLETED","sponsor":"University of Liege","isPivotal":false,"enrollment":19,"indication":"Disorders of Consciousness, Severe Brain Injury","completionDate":"2021-04-28"},{"nctId":"NCT06231043","phase":"Phase 4","title":"Comparative Efficacy of Intramuscular Diclofenac Injection Versus Intravascular Tramadol Injection in Acute Renal Colic, a Randomized Controlled Trial","status":"COMPLETED","sponsor":"Lampang Hospital","isPivotal":false,"enrollment":68,"indication":"Acute Renal Colic","completionDate":"2023-04-15"},{"nctId":"NCT00735748","phase":"Phase 4","title":"Comparison of the Therapeutic Efficacy and Side Effects of Tramadol Per os (Tradonal Odis® Orodispersible Tablets) Versus an Optimised Dosis of Intravenous Tramadol for Postoperative Pain Relief in Am","status":"COMPLETED","sponsor":"University Hospital, Ghent","isPivotal":false,"enrollment":195,"indication":"Pain","completionDate":"2009-06-19"},{"nctId":"NCT01930318","phase":"Phase 4","title":"Effect of COX-2 Selective Inhibitors on Postoperative Insulin Resistance, Tramadol PCA and Early Postoperative Enteral Nutrition in Patients After Gastrointestinal Laparoscopic Surgery","status":"UNKNOWN","sponsor":"Jinling Hospital, China","isPivotal":false,"enrollment":164,"indication":"Gastrointestinal Cancer","completionDate":"2015-09"},{"nctId":"NCT02076893","phase":"Phase 4","title":"A Comparison of Postoperative Tramadol/Gabapentin/Ibuprofen Versus Tramadol/Placebo/Ibuprofen in Children Undergoing Tonsillectomy","status":"TERMINATED","sponsor":"Children's Hospitals and Clinics of Minnesota","isPivotal":false,"enrollment":64,"indication":"Pain","completionDate":"2017-02"},{"nctId":"NCT07051499","phase":"N/A","title":"Effectiveness of TAP Block Versus Intravenous Analgesia in Postoperative Pain Management Following Gynecological Laparoscopic Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Foggia","isPivotal":false,"enrollment":30,"indication":"Postoperative Pain","completionDate":"2026-01-21"},{"nctId":"NCT03134729","phase":"NA","title":"PATHOS Study Pain Assessment in Thoracic Oncologic Surgery: a Prospective Randomized Trial on Pain Management After Video Assisted Major Lung Resections.","status":"COMPLETED","sponsor":"IRCCS Sacro Cuore Don Calabria di Negrar","isPivotal":false,"enrollment":90,"indication":"Pain, Postoperative, Lung Neoplasm","completionDate":"2019-06-04"},{"nctId":"NCT00564603","phase":"Phase 4","title":"Intravenous Continuous Infusion of Dexamethasone Plus Tramadol Combined With Standard Morphine Patient-Controlled Analgesia After Total Abdominal Hysterectomy","status":"COMPLETED","sponsor":"Nanjing Medical University","isPivotal":false,"enrollment":300,"indication":"Postoperative Pain, Post Operative Analgesia","completionDate":"2007-11"},{"nctId":"NCT07386288","phase":"NA","title":"Short-term Effects of Intravenous Dexketoprofen Trometamol and Tramadol on Perfusion-Related Physiological Parameters in Renal Colic","status":"COMPLETED","sponsor":"Ataturk University","isPivotal":false,"enrollment":102,"indication":"Renal Colic","completionDate":"2025-04-30"},{"nctId":"NCT06834243","phase":"N/A","title":"Comparison of Intermittent Bolus and Continuous Infusion Pericapsular Nerve Group Block on Recovery Quality and Analgesic Consumption: a Retrospective Study","status":"COMPLETED","sponsor":"Onur Baran","isPivotal":false,"enrollment":82,"indication":"Hip Surgery, Postoperative Pain Management","completionDate":"2024-11-15"},{"nctId":"NCT01563380","phase":"NA","title":"Efficacy of Autologous Platelet Rich Plasma on Blood Loss, Pain, Wound Healing and Functional Outcome After Total Knee Arthroplasty by a Single Surgeon A Randomized, Prospective, Controlled, Double-bl","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","isPivotal":false,"enrollment":40,"indication":"Blood Loss, Pain","completionDate":"2011-12"},{"nctId":"NCT05311722","phase":"Phase 3","title":"Comparing the Efficacy of Intravenous Dexmedetomidine, Tramadol and Ketamine for Control of Post Spinal Shivering in Obstetric Patients Undergoing Lower Segment C-section","status":"UNKNOWN","sponsor":"Sheikh Zayed Medical College","isPivotal":true,"enrollment":71,"indication":"Post-Surgical Complication","completionDate":"2023-02-20"},{"nctId":"NCT01345162","phase":"Phase 4","title":"Randomized, Prospective Study of the Assessment, Prevention and Management of Acute Post-herniotomy Pain","status":"COMPLETED","sponsor":"Fondazione IRCCS Policlinico San Matteo di Pavia","isPivotal":false,"enrollment":200,"indication":"Hernia","completionDate":"2012-05"},{"nctId":"NCT05886231","phase":"NA","title":"Evaluation of Music Effects on Intraoperative and Postoperative Parameters","status":"COMPLETED","sponsor":"Yuzuncu Yil University","isPivotal":false,"enrollment":80,"indication":"Music and Anesthesia","completionDate":"2020-12-02"},{"nctId":"NCT02291705","phase":"Phase 4","title":"","status":"COMPLETED","sponsor":"Cukurova University","isPivotal":false,"enrollment":40,"indication":"Postoperative Pain","completionDate":"2014-11"},{"nctId":"NCT03586934","phase":"Phase 3","title":"Multimodal Anesthesia and Analgesia for Total Shoulder and Reverse Total Shoulder Arthroplasty: A Randomized Controlled Trial","status":"WITHDRAWN","sponsor":"Rush University Medical Center","isPivotal":true,"enrollment":0,"indication":"Shoulder Pain, Opioid Use","completionDate":"2019-06-01"},{"nctId":"NCT00426647","phase":"Phase 4","title":"A Randomised Double-blind Multicentre Equivalence Study With Active Parallel Comparator Group to Evaluate the Efficacy and Safety of Norspan® Patches Versus Tramadol in Subjects With Chronic, Moderate","status":"COMPLETED","sponsor":"Norpharma A/S","isPivotal":false,"enrollment":120,"indication":"Osteoarthritis, Pain","completionDate":"2009-08"},{"nctId":"NCT02544282","phase":"Phase 4","title":"Large-scale Prospective Double-blind Randomized Controlled Trial of Pecs II Block for Breast Surgery: Effect on Postoperative Pain and Opioid Consumption","status":"COMPLETED","sponsor":"GZA Ziekenhuizen Campus Sint-Augustinus","isPivotal":false,"enrollment":140,"indication":"Pain, Postoperative, Postoperative Nausea and Vomiting","completionDate":"2016-03"},{"nctId":"NCT00737048","phase":"Phase 3","title":"A Double-Blind Comparative Study of JNS013 in Patients With Post-Tooth-Extraction Pain","status":"COMPLETED","sponsor":"Janssen Pharmaceutical K.K.","isPivotal":true,"enrollment":328,"indication":"Pain, Postoperative Pain","completionDate":"2008-09"},{"nctId":"NCT03640247","phase":"Phase 1","title":"Are Narcotic Pain Medications Necessary Following Thyroidectomy and Parathyroidectomy","status":"COMPLETED","sponsor":"MetroHealth Medical Center","isPivotal":false,"enrollment":126,"indication":"Thyroid Disease, Parathyroid Diseases","completionDate":"2019-12-01"},{"nctId":"NCT04147013","phase":"Phase 4","title":"Effect of Celecoxib on Postoperative Narcotic Use and Disease Severity in Patients with Aspirin-exacerbated Respiratory Disease and Chronic Rhinosinusitis: a Randomised Controlled Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's","isPivotal":false,"enrollment":44,"indication":"Chronic Rhinosinusitis with Nasal Polyps, Aspirin-exacerbated Respiratory Disease","completionDate":"2026-07"},{"nctId":"NCT00347685","phase":"Phase 3","title":"Open-label Assessment of the Safety and Effectiveness of Extended Release Tramadol (Tramadol ER) in the Treatment of Chronic Non-malignant Pain.","status":"COMPLETED","sponsor":"Bausch Health Americas, Inc.","isPivotal":true,"enrollment":650,"indication":"Chronic Pain","completionDate":"2003-02"},{"nctId":"NCT00772967","phase":"Phase 1","title":"A Double-Blind, Placebo-Controlled, 3-Period Crossover Study to Evaluate the Analgesic Effects of Naproxen and Ultracet in a Walking Model of Osteoarthritis Knee Pain","status":"COMPLETED","sponsor":"Merck Sharp & Dohme LLC","isPivotal":false,"enrollment":22,"indication":"Osteoarthritis","completionDate":"2008-11"},{"nctId":"NCT06343259","phase":"NA","title":"Comparison of The Effects of General Anesthesia and Spinal Anesthesia on The Development of Postoperative Myocardial Injury in Elderly Patients Undergoing Hip Surgery","status":"RECRUITING","sponsor":"Sisli Hamidiye Etfal Training and Research Hospital","isPivotal":false,"enrollment":100,"indication":"Myocardial Injury After Non-cardiac Surgery, Hypotension During Surgery","completionDate":"2024-08-18"}],"genericFilers":[],"biosimilarFilings":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-01-03","unitCost":"$1.3470/EA","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$492","description":"TRAMADOL HCL 100 MG TABLET","retrievedDate":"2026-04-07"}],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"labelChanges":[],"nice":null,"revenue":null,"regulatoryByCountry":[{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2015-01-20T00:00:00.000Z","mah":"CIPHER PHARMS INC","brand_name_local":null,"application_number":"NDA022370"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2020-05-11T00:00:00.000Z","mah":"UNICHEM","brand_name_local":null,"application_number":"ANDA211825"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2023-12-07T00:00:00.000Z","mah":"TEVA","brand_name_local":null,"application_number":"ANDA075977"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2024-08-02T00:00:00.000Z","mah":"GRAVITI PHARMS","brand_name_local":null,"application_number":"ANDA075968"},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":"2025-12-29T00:00:00.000Z","mah":"SUN PHARM","brand_name_local":null,"application_number":"ANDA091607"},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"SG","regulator":"HSA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AE","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"KR","regulator":"MFDS","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"AU","regulator":"TGA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"GB","regulator":"MHRA","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null},{"country_code":"IL","regulator":"MOH","status":"likely_approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":23,"withResults":1},"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=tramadol","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T00:29:47.514545+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T00:29:52.936227+00:00"},"regulatory.us":{"url":"","method":"api_direct","source":"FDA Drugs@FDA","rawText":"","confidence":1,"sourceType":"fda_drugsfda","retrievedAt":"2026-04-20T00:29:46.643601+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=tramadol","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T00:29:53.177426+00:00"},"administration.route":{"url":"","method":"deterministic","source":"FDA Label","rawText":"","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:29:41.082337+00:00"},"safety.boxedWarnings":{"url":"","method":"deterministic","source":"FDA Label (boxed_warning)","rawText":"WARNING: SERIOUS AND LIFE-THREATENING RISKS FROM USE OF TRAMADOL HYDROCHLORIDE EXTENDED-RELEASE TABLETS Addiction, Abuse, and Misuse Because the use of tramadol hydrochloride extended-release tablets exposes patients and other users to the risks of opioid addiction, abuse, and misuse, which can lead to overdose and death, assess each patient’s risk prior to prescribing and reassess all patients regularly for the development of these behaviors and conditions [see Warnings and Precautions (5.1)] .","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:29:41.082367+00:00"},"safety.safetySignals":{"url":"https://api.fda.gov/drug/event.json","method":"api_direct","source":"FDA FAERS","rawText":"","confidence":1,"sourceType":"fda_faers","retrievedAt":"2026-04-20T00:29:54.855513+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Mu opioid receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:29:54.212240+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1237065/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T00:29:53.876972+00:00"},"regulatory.fda_application":{"url":"","method":"deterministic","source":"FDA Label","rawText":"ANDA201384","confidence":1,"sourceType":"fda_label","retrievedAt":"2026-04-20T00:29:41.082371+00:00"}},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T00:29:57.943549+00:00","fieldsConflicting":0,"overallConfidence":0.95},"crossReferences":{"chemblId":"CHEMBL1237065"},"verificationStatus":"verified","dataCompleteness":{"mechanism":false,"indications":true,"safety":true,"trials":true,"score":3}}